HK Stock Market Move | JINHAI MED TECH (02225) rose over 10% in early trading, with former GE Healthcare and Medtronic executive Ma Chengdong appointed as the company's Chief Marketing Officer.

JINHAI MED TECH (02225) rose over 10% in early trading, and as of the time of writing, it is up 10%, priced at HKD 4.345, with a trading volume of HKD 11.77 million. On August 3, JINHAI MED TECH announced the appointment of Mr. Ma Chengdong as the Group's Chief Marketing Officer, effective from August 3, 2026, for an initial term of one year. According to the announcement, Mr. Ma Chengdong will mainly be responsible for the marketing strategy, market access, academic promotion, sales, and channel operations of the Group's products, as well as overseeing the commercialization of the Group's medical devices and equipment products. Mr. Ma is 55 years old and graduated from Shanghai Medical University (now known as Fudan University Shanghai Medical College), majoring in Clinical Medicine, and completed a five-year residency training at the Shanghai Institute of Cardiovascular Diseases. He has over 25 years of extensive experience in international medical enterprises, having held various positions at GE Healthcare (China) Ltd., including Technical Manager, Product Manager, Regional Sales Director, Marketing Manager for Greater China, Acting General Manager for Greater China, and General Manager of Clinical Applications and Research Team. He also served as the Senior Director of the CSOT Strategic Marketing Department and Senior Director of Business Excellence Operations at Medtronic (Shanghai) Management Co., Ltd.